A major clinical trial, which included 13 patients from National University Hospital, showed that the drug lecanemab slowed cognitive and functional decline in participants aged 50 to 90 with early Alzheimer’s disease.
In The Straits Times’ The Big Story, Multimedia Correspondent Cheow Sue-Ann speaks with Associate Professor Christopher Chen, a Visiting Consultant in the Department of Psychological Medicine at NUH about the research.

What’s Trending: Would you $30,000 for a wedding cake and trust a viral aluminum foil door hack?
16:53

The Big Story: Malacca Strait levy talk - Could it ever actually happen?
12:36

Wealth Tracker: Why US buyers are returning to Japan stocks
13:37